Haitian Creole
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Paj 1 soti nan 26 rezilta yo
Treatment method
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF THE INVENTION
The invention relates to methods of treating mammals, for example humans, to reduce the occurrence of undesired administration reactions, to treat an LFA-1 mediated disease, to condition a mammal to tolerate high doses of a therapeutic compound and to down modulate a cell
Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF THE INVENTION
The invention relates to methods of treating mammals, for example humans, to reduce the occurrence of undesired administration reactions, to treat an LFA-1 mediated disease, to condition a mammal to tolerate high doses of a therapeutic compound and to down modulate a cell
Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF THE INVENTION
The invention relates to methods of treating mammals, for example humans, to reduce the occurrence of undesired administration reactions, to treat an LFA-1 mediated disease, to condition a mammal to tolerate high doses of a therapeutic compound and to down modulate a cell
Antipyretic and analgesic methods of using optically pure R-etodolac
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
This invention relates to novel compositions of matter containing optically pure R-etodolac. These compositions possess potent activity in treating pain including, but not limited to, pain associated with toothaches, headaches, sprains, joint pain and surgical pain, for
Antipyretic and analgesic methods using optically pure R-ketorolac
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
This invention relates to novel compositions of matter containing optically pure R-ketorolac. These compositions possess potent activity in treating pain, including but not limited to pain associated with toothaches, headaches, sprains, joint pain and surgical pain, for
Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
This invention relates to novel compositions of matter containing optically pure R(-) ketoprofen. These compositions possess potent activity in treating pain including but not limited to, pain associated with toothaches, headaches, sprains, joint pain and surgical pain,
Modulation of substance P by compounds containing calcium sulfate and methods relating thereto
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present invention relates generally to a method of modulating substance P by compounds containing calcium sulfate, particularly syngenite, gorgeyite and gypsum, and more specifically, to the synthesis of such compounds as well as their use to treat a variety of conditions
Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
This invention relates to compounds and pharmaceutical compositions for the treatment of cyclooxygenase mediated diseases and methods of treating thereof.
Non-steroidal, antiinflammatory drugs exert most of their antiinflammatory, analgesic and antipyretic activity and
Crystal structure of human coronavirus 229E main proteinase and uses for developing SARS inhibitors
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to human coronavirus 229E main proteinase (M.sup.pro) and uses in the development of inhibitors for Severe Acute Respiratory Syndrome (SARS).
2. Description of the Prior Art
Human coronaviruses (HCoV) are major causes of
Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present invention is directed to certain isoxazolone compounds that inhibit the release of inflammatory cytokines such as interleukin-1 (IL-1) and tumor necrosis factor (TNF) from cells. The compounds of the invention, therefore, are useful in treating diseases involving unwanted
Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present invention is directed to certain isoxazolone compounds that inhibit the release of inflammatory cytokines such as interleukin-1 (1L-1) and tumor necrosis factor (TNF) from cells. The compounds of the invention, therefore, are useful in treating diseases involving unwanted
Ibuprofen intravenous infusion
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
DETAILED DESCRIPTION
Definition of the Relevant Field of the Invention
Human drugs (Pharmaceuticals), therapeutic class, Analgesics, Non-steroidal Anti-inflammatory Agents.
Professional Background of the Applicant
The product in question is a novel pharmaceutical formulation that compromises a 4
Pharmaceutical composition for preventing / treating TRPV1 activity-related and inflammation-related diseases or conditions containing maillard peptide separated from well-aged traditional soy sauce as active ingredient
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a 371 of PCT/KR2010/007845, filed Nov. 8, 2010, which claims the benefit of Korean Patent Application No. 10-2009-0106912, filed Nov. 6, 2009, the entire contents of each of which are incorporated herein by reference.
TECHNICAL FIELD
The
Cough/cold mixtures comprising non-sedating antihistamine drugs
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
Appicants have filed a number of applications concerning cough/cold formulations containing the newer non-steroidal anti-inflammatory drugs. These applications which are assigned to Richardson-Vicks, Inc. include U.S. Ser. No. 042,120, filed Apr. 24, 1987, now U.S. Pat. No. 4,783,465 which is a
Cough/cold mixtures comprising non-sedating antihistamine drugs
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
Applicants have filed a number of applications concerning cough/cold formulations containing the newer non-steroidal anti-inflammatory drugs. These applications which are assigned to Richardson-Vicks, Inc. include U.S. Ser. No. 042,120, filed Apr. 24, 1987, now U.S. Pat. No. 4,783,465 which is a
Baz done ki pi konplè remèd fèy medsin te apiye nan syans
- Travay nan 55 lang
- Geri èrbal te apiye nan syans
- Remèd fèy rekonesans pa imaj
- Kat entèaktif GPS - tag zèb sou kote (vini byento)
- Li piblikasyon syantifik ki gen rapò ak rechèch ou an
- Search remèd fèy medsin pa efè yo
- Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive
Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye
